Men Having Sex With Men Donor Deferral Risk Assessment: An Analysis Using Risk Management Principles

Transfusion Medicine Reviews

Volumn 22, Issue 1, 2008, Pages 35-57

  Leiss, William ^a   Tyshenko, Michael ^a   Krewski, Daniel ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CANADA; ETHICS; HEALTH CARE POLICY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; PATIENT SAFETY; RISK ASSESSMENT; RISK MANAGEMENT;

BLOOD DONORS; CANADA; DIAGNOSTIC ERRORS; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; ORGANIZATIONAL POLICY; PERCEPTION; RISK ASSESSMENT; RISK FACTORS; RISK MANAGEMENT; STEREOTYPING;

EID: 36549061103     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2007.09.002     Document Type: Article

References (42)

1. United States, Food and Drug Administration. Workshop on Behavior-Based Donor Deferrals in the NAT Era. Transcript, minutes of meeting, Bethesda, MD, 8 March 2006. http://www.fda.gov/cber/minutes/nato30806t.pdf
2. King S.M., AuBuchon J., Barrowman N., et al. Consensus statement from the consensus conference on blood-borne HIV and hepatitis. Vox Sang 83 (2002) 188-193
3. Chiavetta J.A., Deeks S., Goldman M., et al. Proceedings of a Consensus Conference: Blood-Borne HIV and Hepatitis-Optimizing the Donor Selection Process. Transfus Med Rev 17 (2003) 1-30
4. Damesyn M.A., Glynn S., Schreiber G., et al., for the NHLBI Retrovirus Epidemiology Donor Study. Behavioral and infectious disease risks in young blood donors. Transfusion 43 (2003) 1596-1603
5. Sanchez A.M., Schreiber G.B., Nass C.C., et al., for the Retrovirus Epidemiology Donor Study. The impact of male-to-male sexual experience on risk profiles of blood donors. Transfusion 45 (2005) 404-413
6. Sellors J.W., Hayward R., Swanson G., et al. Comparison of deferral rates using a computerized versus written blood donor questionnaire. BMC Public Health 2 (2002) 14
7. Rugege-Hakiza S.E., Glynn S., Hutching S., et al., for the Retrovirus Epidemiology Donor Study. Do blood donors read and understand screening educational materials?. Transfusion 43 (2003) 1075-1083
8. O'Brien S., Yi Q.-L., Fan W., et al. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 47 (2007) 316-325
9. McColl R.S., Hicks J., and Craig L. Environmental health risk management: a primer for Canadians. Waterloo, ON: Institute for Risk Research, 2002. http://www.irr-neram.ca/pubs/reports/reports.html#primer
10. Hrudey S., and Leiss W. Risk management and precaution: insights on the cautious use of evidence. Environ Health Perspect 111 (2003) 1577-1581
11. United States, Office of Management and Budget. Proposed risk assessment bulletin 2006. http://www.whitehouse.gov/omb/inforeg/proposed_risk_assessment_bulletin_010906.pdf
12. United States, National Research Council. Science and judgment in risk assessment (1994), National Academy Press, Washington, DC
13. United States, National Research Council. Understanding risk (1996), National Academy Press, Washington, DC
14. Tyshenko M, Krewski D. Public perception and acceptable levels of health risk among Canadians. Unpublished paper, McLaughlin Centre, University of Ottawa, 2005
15. Wilde G.J.S. Target risk 2 (2001), PDE Publications, Toronto, ON
16. Health Canada. Assessment and management of cancer risks from radiological and chemical hazards, 1998. http://www.hc-sc.gc.ca/ewh-semt/pubs/radiation/98ehd-dhm216/index_e.html
17. Krever. The honourable Mr. Justice Horace. Commission of Inquiry on the Blood System in Canada: Final Report, vol. I (1997), Government of Canada, Ottawa
18. In: Harremoës P., Gee D., MacGarvin M., et al. (Eds). The precautionary principle in the 20th century (2002), Earthscan, London
19. Germain M., Remis R.S., and Delage G. The risks and benefits of accepting men who have had sex with men as blood donors. Transfusion 43 (2003) 25-33
20. Spencer B., Rios J., and Cable R. Marginal recruitment impact of potential alterations to FDA deferral criteria for men who have had sex with men. [letter]. Transfusion 46 (2006) 869-870
21. New Zealand, Environmental Risk Management Agency. Ethics framework, Dec. 2005. http://www.ermanz.govt.nz/resources/publications/pdfs/ER-PR-05-1.pdf
22. World Health Organization. World Health Report 2002, Chapter 6, Section 6: "Ethical considerations in risk prevention". http://www.who.int/whr/2002/chapter6/en/index5.html
23. Beauchamp T.L., and Childress J.F. Principles of medical ethics. ed 5 (2001), Oxford University Press, New York
24. Wilson K., and Hebert P.C. The challenge of an increasingly expensive blood system. CMAJ 168 (2003) 1149-1150
25. Kleinman S., Chan A., and Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 17 (2003) 120-162
26. United States, Food and Drug Administration, Blood Products Advisory Committee. Transcript, minutes of meeting, Bethesda, MD, 9 March 2006. http://www.fda.gov/ohrms/dockets/ac/06/transcripts/2006-4206t1.pdf
27. Boulos D., Yan P., Schanzer D., et al. Estimates of HIV prevalence and incidence in Canada, 2005. Can Commun Dis Rep 32 (2006) 165-175. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/06vol32/dr3215 http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/06vol32/dr3215
28. Myers T., and Allman D. 2004 Ontario Men's Survey. HIV Social, Behavioural and Epidemiological Studies Unit, University of Toronto, Toronto, ON, 2004. http://cbr.cbrc.net/files/1126039797/Ontario%20Mens%20Survey%20Final%20Report.pdf
29. Germain M., and Sher G. Men who have had sex with men and blood donation: is it time to change our deferral criteria?. J Int Assoc Physicians AIDS Care 1 (2002) 86-88
30. In: Flynn J., Slovic P., and Kunreuther H. (Eds). Risk, media and stigma (2001), Earthscan, London
31. Dollard C. Transmission of HHV-8 by blood transfusion. In: FDA Workshop (Ref 1)
32. Blajchman M.A., and Vamvakas E.C. The continuing risk of transfusion-transmitted infections. N Engl J Med 355 (2006) 1303-1305
33. Hladik W., Dollard S.C., Mermin J., et al. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 355 (2006) 1331-1338
34. Chiavetta J.A., Escobar M., Newman A., et al. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ 169 (2003) 767-773
35. Soldan K., Davison S., and Dow B. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Eurosurveillance 10 (2005) 17-19
36. Dodd R.Y., Notari E.P., and Stramer S.L. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42 (2002) 975-979
37. Busch M.P., Glynn S.A., Stramer S.L., et al., for the NHLBI-REDS NAT Study Group. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 45 (2005) 254-264
38. Soldan K., and Sinka K. Evaluation of the de-selection of men who have had sex with men from blood donation in England. Vox Sang 84 (2003) 265-273
39. Galt V. It's okay to be gay on Bay. The Globe and Mail, Toronto, ON, July 12, 2006, p. C1
40. Hewitt P.E., Llewelyn C.A., Mackenzie J., et al. Creutzfeldt-Jakob disease and blood transfusion: Results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 91 (2006) 221-230
41. Burnouf T., and Padilla A. Current strategies to prevent transmission of prions by human plasma derivatives. Transfus Clin Biol 13 (2006) 320-328
42. Rai S.N., Krewski D., and Bartlett S. A general framework for the analysis of uncertainty and variability in risk assessment. Hum Ecol Risk Assess 2 (1996) 972-989